Home
About
Directory
Promoted Listings
Purchase Data
Drug Pipelines
Weekly Update
Data Licensing
Contact
Chelsea Therapeutics
is defunct.
Acquired by Lundbeck, June 2014, up to $658M
------------------
If you believe any of this information is incorrect, please
let us know
.